Fig. 8
From: Human fetal mesenchymal stem cell secretome enhances bone consolidation in distraction osteogenesis
Immunohistochemical analysis of the percentages of Osx- and OCN-positive cells in the distraction zone. The secretome treatment has significantly increased numbers of Osx (A–D) and OCN (a-d) positive cells (brown) compared to the PBS and medium treatment (**p < 0.01). hFMSC human fetal mesenchymal stem cell, OCN osteocalcin, Osx osterix, PBS phosphate-buffered saline